Abstract
References
Etuwewe O, Kulshrestha R, Sangra M et al. Brain abscesses due to Citrobacter koseri in a pair of twins. The Pediatric Infectious Disease Journal 2009;28(11):1035. Available from: https://doi.org/10.1097/INF.0b013e3181b6b064.
Kariholu U, Rawal J, Namnyak S. Neonatal Citrobacter koseri meningitis and brain abscess. Internet J Pediatr Neonatol. 2009;10:1.
Berk SL, McCabe WR. Meningitis caused by gram-negative bacilli. Annals of Internal Medicine 1980;93(2):253-60. Available from: https://doi.org/10.7326/0003-4819-93-2-253
Tang LM, Chen ST, Lui TN. Citrobacter meningitis in adults. Clinical Neurology and Neurosurgery 1994;96(1):52-7. Available from: https://doi.org/10.1016/0303-8467(94)90030-2
Scheld WM, Tyson GW. Citrobacter freundii meningitis in an adult. Southern Medical Journal 1979;72(12):1598. Available from: https://doi.org/10.1097/00007611-197912000-00031
Madrazo A, Geiger J, Lauter CB. Citrobacter diversus at Grace Hospital, Detroit, Michigan. The American Journal of the Medical Sciences 1975;270(3):497-501. Available from: https://doi.org/10.1097/00000441-197511000-00011
Lin SY, Ho MW, Yang YF et al. Abscess caused by Citrobacter koseri infection: three case reports and a literature review. Internal Medicine 2011;50(12):1333-7. Available from: https://doi.org/10.2169/internalmedicine.50.4962
Booth LV, Palmer JD, Pateman J et al. Citrobacter diversus ventriculitis and brain abscesses in an adult. Journal of Infection 1993;26(2):207-9. Available from: https://doi.org/10.1016/0163-4453(93)93058-c
Lind CR, Muthiah K, Bok AP. Peritumoral Citrobacter koseri abscess associated with parasagittal meningioma. Neurosurgery 2005;57(4):E814-. Available from: https://doi.org/10.1093/neurosurgery/57.4.e814
Smolen JS, Landewé R, Bijlsma J et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases 2017;76(6):960-77. Available from: https://doi.org/10.1136/annrheumdis-2016-210715
Jones G, Sebba A, Gu J et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases 2010;69(01):88-96. Available from: https://doi.org/10.1136/ard.2008.105197
Nishimoto N, Miyasaka N, Yamamoto K. et al. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Modern Rheumatology 2009;19(1):12-9. Available from: https://doi.org/10.1007/s10165-008-0125-1